These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9988 related articles for article (PubMed ID: 11345308)

  • 1. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000).
    Rassnick KM; Ruslander DM; Cotter SM; Al-Sarraf R; Bruyette DS; Gamblin RM; Meleo KA; Moore AS
    J Am Vet Med Assoc; 2001 May; 218(9):1444-8. PubMed ID: 11345308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
    Dank G; Rassnick KM; Sokolovsky Y; Garrett LD; Post GS; Kitchell BE; Sellon RK; Kleiter M; Northrup N; Segev G
    Vet Comp Oncol; 2014 Mar; 12(1):78-84. PubMed ID: 22737988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of chemotherapeutic effect without wide-margin surgery or radiation therapy in dogs with oral malignant melanoma.
    Xia Y; Liao AT; Lee J
    Can Vet J; 2024 Apr; 65(4):343-350. PubMed ID: 38562982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
    Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
    J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of platinum content in biodegradable carboplatin-impregnated beads and retrospective assessment of tolerability for intralesional use of the beads in dogs following excision of subcutaneous sarcomas: 29 cases (2011-2014).
    Hess TA; Drinkhouse ME; Prey JD; Miller JM; Fettig AA; Carberry CA; Brenn SH; Bailey DB
    J Am Vet Med Assoc; 2018 Feb; 252(4):448-456. PubMed ID: 29393745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
    Boria PA; Murry DJ; Bennett PF; Glickman NW; Snyder PW; Merkel BL; Schlittler DL; Mutsaers AJ; Thomas RM; Knapp DW
    J Am Vet Med Assoc; 2004 Feb; 224(3):388-94. PubMed ID: 14765798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.
    Wouda RM; Hocker SE; Higginbotham ML
    Vet Comp Oncol; 2018 Mar; 16(1):E52-E60. PubMed ID: 28799187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder.
    Chun R; Knapp DW; Widmer WR; DeNicola DB; Glickman NW; Kuczek T; Degortari A; Han CM
    J Vet Intern Med; 1997; 11(5):279-83. PubMed ID: 9348494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog.
    Bailey D; Erb H; Williams L; Ruslander D; Hauck M
    J Vet Intern Med; 2003; 17(2):199-205. PubMed ID: 12683621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of concurrent carboplatin chemotherapy and radiation therapy in dogs.
    Hume KR; Johnson JL; Williams LE
    J Vet Intern Med; 2009; 23(1):24-30. PubMed ID: 19175716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012).
    Boston SE; Lu X; Culp WT; Montinaro V; Romanelli G; Dudley RM; Liptak JM; Mestrinho LA; Buracco P
    J Am Vet Med Assoc; 2014 Aug; 245(4):401-7. PubMed ID: 25075823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined gemcitabine and carboplatin therapy for carcinomas in dogs.
    Dominguez PA; Dervisis NG; Cadile CD; Sarbu L; Kitchell BE
    J Vet Intern Med; 2009; 23(1):130-7. PubMed ID: 19175731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987-1997).
    Freeman KP; Hahn KA; Harris FD; King GK
    J Vet Intern Med; 2003; 17(1):96-101. PubMed ID: 12564733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
    Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
    Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of nab-paclitaxel combined with carboplatin in Chinese patients with melanoma.
    Guo YQ; Ding Y; Li DD; Li JJ; Peng RQ; Wen XZ; Zhang X; Zhang XS
    Med Oncol; 2015 Sep; 32(9):234. PubMed ID: 26298530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
    Stanclift RM; Gilson SD
    J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.
    Grant IA; Rodriguez CO; Kent MS; Sfilgoi G; Gordon I; Davis G; Lord L; London CA
    J Vet Intern Med; 2008; 22(2):388-93. PubMed ID: 18312556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
    Gillem J; Giuffrida M; Krick E
    Vet Comp Oncol; 2017 Jun; 15(2):400-410. PubMed ID: 26463827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs.
    Pritchard C; Al-Nadaf S; Rebhun RB; Willcox JL; Skorupski KA; Lejeune A
    Vet Comp Oncol; 2023 Dec; 21(4):717-725. PubMed ID: 37705417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 500.